These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. p53-dependent R-loop formation and HPV pathogenesis. Templeton CW; Laimins LA Proc Natl Acad Sci U S A; 2023 Aug; 120(35):e2305907120. PubMed ID: 37611058 [TBL] [Abstract][Full Text] [Related]
3. RNA-Seq Analysis of Differentiated Keratinocytes Reveals a Massive Response to Late Events during Human Papillomavirus 16 Infection, Including Loss of Epithelial Barrier Function. Klymenko T; Gu Q; Herbert I; Stevenson A; Iliev V; Watkins G; Pollock C; Bhatia R; Cuschieri K; Herzyk P; Gatherer D; Graham SV J Virol; 2017 Dec; 91(24):. PubMed ID: 29021401 [TBL] [Abstract][Full Text] [Related]
4. FANCD2 Binds Human Papillomavirus Genomes and Associates with a Distinct Set of DNA Repair Proteins to Regulate Viral Replication. Spriggs CC; Laimins LA mBio; 2017 Feb; 8(1):. PubMed ID: 28196964 [TBL] [Abstract][Full Text] [Related]
5. Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia. Hu T; Yang P; Zhu H; Chen X; Xie X; Yang M; Liu S; Wang H Diagn Pathol; 2015 Apr; 10():20. PubMed ID: 25885042 [TBL] [Abstract][Full Text] [Related]
6. STAT-5 Regulates Transcription of the Topoisomerase IIβ-Binding Protein 1 (TopBP1) Gene To Activate the ATR Pathway and Promote Human Papillomavirus Replication. Hong S; Cheng S; Iovane A; Laimins LA mBio; 2015 Dec; 6(6):e02006-15. PubMed ID: 26695634 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia. Yang W; Song Y; Lu YL; Sun JZ; Wang HW Immunology; 2013 Aug; 139(4):513-22. PubMed ID: 23521696 [TBL] [Abstract][Full Text] [Related]
8. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. Clerici M; Merola M; Ferrario E; Trabattoni D; Villa ML; Stefanon B; Venzon DJ; Shearer GM; De Palo G; Clerici E J Natl Cancer Inst; 1997 Feb; 89(3):245-50. PubMed ID: 9017005 [TBL] [Abstract][Full Text] [Related]
9. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955 [TBL] [Abstract][Full Text] [Related]
10. Understanding HLA-G driven journey from HPV infection to cancer cervix: Adding missing pieces to the jigsaw puzzle. Aggarwal R; Sharma M; Mangat N; Suri V; Bhatia T; Kumar P; Minz R J Reprod Immunol; 2020 Nov; 142():103205. PubMed ID: 33099242 [TBL] [Abstract][Full Text] [Related]
11. Topoisomerase IIβ-binding protein 1 activates expression of E2F1 and p73 in HPV-positive cells for genome amplification upon epithelial differentiation. Hong S; Xu J; Li Y; Andrade J; Hoover P; Kaminski PJ; Laimins LA Oncogene; 2019 Apr; 38(17):3274-3287. PubMed ID: 30631149 [TBL] [Abstract][Full Text] [Related]
12. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection. Li B; Hu Y; Ye F; Li Y; Lv W; Xie X Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590 [TBL] [Abstract][Full Text] [Related]
14. Local expression of interferon-alpha and interferon receptors in cervical intraepithelial neoplasia. Tirone NR; Peghini BC; Barcelos AC; Murta EF; Michelin MA Cancer Immunol Immunother; 2009 Dec; 58(12):2003-10. PubMed ID: 19381629 [TBL] [Abstract][Full Text] [Related]
15. Expression of HPV-induced DNA Damage Repair Factors Correlates With CIN Progression. Spriggs CC; Blanco LZ; Maniar KP; Laimins LA Int J Gynecol Pathol; 2019 Jan; 38(1):1-10. PubMed ID: 29995652 [TBL] [Abstract][Full Text] [Related]
16. IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes. DeCarlo CA; Severini A; Edler L; Escott NG; Lambert PF; Ulanova M; Zehbe I Lab Invest; 2010 Oct; 90(10):1482-91. PubMed ID: 20479716 [TBL] [Abstract][Full Text] [Related]
17. TNFalpha polymorphism frequencies in HPV-associated cervical dysplasia. Kirkpatrick A; Bidwell J; van den Brule AJ; Meijer CJ; Pawade J; Glew S Gynecol Oncol; 2004 Feb; 92(2):675-9. PubMed ID: 14766265 [TBL] [Abstract][Full Text] [Related]
18. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri. Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043 [TBL] [Abstract][Full Text] [Related]
19. Aberrant, highly hyperdiploid cells in human papillomavirus-positive, abnormal cytologic samples are associated with progressive lesions of the uterine cervix. Bollmann R; Méhes G; Speich N; Schmitt C; Bollmann M Cancer; 2005 Apr; 105(2):96-100. PubMed ID: 15662700 [TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer. de Wilde J; Wilting SM; Meijer CJ; van de Wiel MA; Ylstra B; Snijders PJ; Steenbergen RD Int J Cancer; 2008 Feb; 122(4):877-88. PubMed ID: 17960611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]